Quantum Biopharma (QNTM) Stock Price, News & Analysis

Company Overview

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $5.05 to $5.29
• 50-Day Range: $3.76 to $7.55
• 52-Week Range: $3.50 to $97.50
• Volume: 35,429 shs
• Average Volume: 164,973 shs
• Market Capitalization: $6.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

QNTM Stock Analysis - Frequently Asked Questions

How have QNTM shares performed this year?

Quantum Biopharma's stock was trading at $4.10 at the start of the year. Since then, QNTM stock has increased by 27.8% and is now trading at $5.24.
View the best growth stocks for 2024 here.

How do I buy shares of Quantum Biopharma?

Shares of QNTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Quantum Biopharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Quantum Biopharma investors own include Jiuzi (JZXN), Aethlon Medical (AEMD), Aditxt (ADTX), Adial Pharmaceuticals (ADIL), Avalon GloboCare (ALBT), Ainos (AIMD) and AMC Entertainment (AMC).

Company Calendar

• Today: 11/14/2024
• Fiscal Year End: 12/31/2024
• Next Earnings (Estimated): 3/27/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:QNTM
• CUSIP: N/A
• CIK: 1771885
• Web: www.fsdpharma.com
• Phone: 416-854-8884
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($15.4090)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-17,900,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -91.14%
• Return on Assets: -65.53%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.99
• Quick Ratio: 1.99

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $21.29 per share
• Price / Book: 0.25

Miscellaneous

• Outstanding Shares: 1,300,000
• Free Float: 1,190,000
• Market Cap: $6.81 million
• Optionable: N/A
• Beta: 0.56